WO2001009154A3 - USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN - Google Patents

USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN Download PDF

Info

Publication number
WO2001009154A3
WO2001009154A3 PCT/US2000/020735 US0020735W WO0109154A3 WO 2001009154 A3 WO2001009154 A3 WO 2001009154A3 US 0020735 W US0020735 W US 0020735W WO 0109154 A3 WO0109154 A3 WO 0109154A3
Authority
WO
WIPO (PCT)
Prior art keywords
isoleucyl
staphylococcus aureus
trna synthetase
crystal structure
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/020735
Other languages
French (fr)
Other versions
WO2001009154A2 (en
Inventor
Jimin Wang
Laura F Silvian
Thomas A Steitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Priority to EP00950881A priority Critical patent/EP1200564A2/en
Priority to CA002380335A priority patent/CA2380335A1/en
Priority to AU63915/00A priority patent/AU6391500A/en
Publication of WO2001009154A2 publication Critical patent/WO2001009154A2/en
Publication of WO2001009154A3 publication Critical patent/WO2001009154A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides the atomic coordinates derived from high resolution x-ray diffraction of the cocrystal complex comprising mupirocin with its target enzyme, isoleucyl-tRNA synthetase form Staphylococcus aureus, and the cognate tRNAile from Escherichia coli. The present invention further provides methods of using the atomic coordinates to identify and design new agents which modulate protein synthesis as well as the agents themselves.
PCT/US2000/020735 1999-07-29 2000-07-31 USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN Ceased WO2001009154A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00950881A EP1200564A2 (en) 1999-07-29 2000-07-31 USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN
CA002380335A CA2380335A1 (en) 1999-07-29 2000-07-31 Use of the crystal structure of staphylococcus aureus isoleucyl-trna synthetase in antibiotic design
AU63915/00A AU6391500A (en) 1999-07-29 2000-07-31 Use of the crystal structure of staphylococcus aureus isoleucyl-trna synthetase in antibiotic design

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14617699P 1999-07-29 1999-07-29
US60/146,176 1999-07-29

Publications (2)

Publication Number Publication Date
WO2001009154A2 WO2001009154A2 (en) 2001-02-08
WO2001009154A3 true WO2001009154A3 (en) 2001-07-26

Family

ID=22516158

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/020735 Ceased WO2001009154A2 (en) 1999-07-29 2000-07-31 USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN

Country Status (5)

Country Link
US (1) US6631329B1 (en)
EP (1) EP1200564A2 (en)
AU (1) AU6391500A (en)
CA (1) CA2380335A1 (en)
WO (1) WO2001009154A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013167A2 (en) * 2002-08-01 2004-02-12 Affinium Pharmaceuticals, Inc. Purified polypeptides from enterococcus faecalis
US20070118296A1 (en) * 2003-11-07 2007-05-24 Dna Software Inc. System and methods for three dimensional molecular structural analysis
EP2066789A4 (en) * 2006-09-29 2009-12-30 Anacor Pharmaceuticals Inc CRYSTAL STRUCTURE OF A TRNA SYNTHETASE
CN112933243B (en) * 2021-01-25 2023-06-27 中山大学 Complex crystal of isoleucyl tRNA synthetase and Lei Fumei element A, and preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
L F SILVIAN ET AL.: "Insights into editing from an Ile-t RNAS synthetase structure with tRNA and mupirocin", SCIENCE., vol. 285, 13 August 1999 (1999-08-13), AAAS. LANCASTER, PA., US, pages 1074 - 1077, XP002160175 *
O NUREKI ET AL.: "Enzyme structure with two catalytic sites for double-sieve selection of substrates", SCIENCE., vol. 280, 24 April 1998 (1998-04-24), AAAS. LANCASTER, PA., US, pages 578 - 582, XP002160173 *
S P HALE ET AL.: "Discrete determinants in transfer RNA for editing and aminoacylation", SCIENCE., vol. 276, 23 May 1997 (1997-05-23), AAAS. LANCASTER, PA., US, pages 1250 - 1252, XP002160174 *

Also Published As

Publication number Publication date
CA2380335A1 (en) 2001-02-08
AU6391500A (en) 2001-02-19
US6631329B1 (en) 2003-10-07
WO2001009154A2 (en) 2001-02-08
EP1200564A2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
Landini et al. Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal
Abouelhassan et al. Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy
Czaplewski et al. Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
UA86413C2 (en) Normal;heading 1;heading 2;SUGAR COATING AND SOLID DOSAGE FORM CONTAINING THEREOF
WO2019002218A3 (en) Altering microbial populations & modifying microbiota
CY1118065T1 (en) INNOVATIVE AMINOGLYCOSIDES AND THEIR USES IN THE TREATMENT OF GENETIC DISORDERS
WO2005019241A3 (en) Cationic antimicrobial peptides and compositions thereof
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
DK0746327T3 (en) Acidified nitrite as an antimicrobial agent
SV1999000194A (en) PHARMACEUTICAL PREPARATION OF MOXIFLOXACINE REF. READ 33327-SV
EP1188769A8 (en) High resolution crystal structure of the ribosome and design of protein synthesis inhibitors
BR9205760A (en) Antimicrobial proteins, pure MJ-AMPI protein, pure proteins, recombinant DNA sequence, vector, biological system, plants, antimicrobial composition, process to fight fungi or bacteria and extraction process to produce biocidally active proteins
Lyu et al. Multiple complexes of long aliphatic N-acyltransferases lead to synthesis of 2, 6-diacylated/2-acyl-substituted glycopeptide antibiotics, effectively killing vancomycin-resistant enterococcus
Patel et al. Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY
AU2001259303A1 (en) Glycopeptide carboxy-saccharide derivatives
WO2001009154A3 (en) USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN
DK165120C (en) BASIC MONOCARBOXYAMIDE DERIVATIVES OF ACTAGARDIN, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE DERIVATIVES
EP1066045A4 (en) MAMMAL COMBAT PEPTIDES FOR TREATING MICROBIAL INFECTIONS
RU94019991A (en) Antibiotic composition
WO2003101405A3 (en) Aminoglycoside antibiotics and methods of using same
AU2001235696A1 (en) Compositions useful for regulating parkin gene activity
WO2004108744A3 (en) Azalides and azaketolides having antimicrobial activity
HUP0202166A3 (en) Global regulators of bacterial pathogenic genes: bacterial autoinducer inactivation protein, as targets for engineering disease resistance
WO2002078720A3 (en) Antibiotics from bacteria isolated from amphibian skin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2380335

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000950881

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000950881

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000950881

Country of ref document: EP